EPO pharma case law trends 2025: Antibodies and biologics By Dr Rose Hughes on Monday, November 17, 2025 antibodies antibody inventions biologics epo EPO Boards of Appeal PatKat Rose Hughes +
Can infringement be avoided by performing part of a diagnostic method claim in another jurisdiction? By Dr Claire Gregg on Monday, November 17, 2025 Australia Claire Gregg diagnostic methods infringement OzKat patents +
Sunday Surprises By Verónica Rodríguez Arguijo on Sunday, November 16, 2025 AI AI training Artificial Intelligence events GEMA v OpenAI Getty Images v Stability AI IP News Miscellany opportunities Sunday Surprises TechieKat Verónica Rodríguez Arguijo +
Best-case scenario for Puma? By Söğüt Atilla-Aydın on Sunday, November 16, 2025 figurative marks marks with a reputation puma Söğüt Atilla-Aydın T-491/24 trade marks +
[Guest Book Review] Publishers’ Rights and Copyright Law By Jocelyn Bosse on Friday, November 14, 2025 Book review copyright press publishers' right Simone Driusso +
Freedom of expression is only "due cause" if targeted at the trade mark holder, says Advocate General in IKEA-PLAN opinion By Jocelyn Bosse on Thursday, November 13, 2025 due cause Freedom of expression IKEA Jocelyn Bosse marks with a reputation trade marks +
Never Too Late: If you missed the IPKat last week! By Kliment Markov on Thursday, November 13, 2025 #NeverTooLate AI Artificial Intelligence copyright Kliment Markov patents Personality rights trade marks +
Why you still can't have your cake and eat it too: "best method" lives on in Australia By Dr Claire Gregg on Wednesday, November 12, 2025 Australia best method Claire Gregg OzKat patents +
First use of G 1/24 to broaden clear claim language (T 1849/23) By Dr Rose Hughes on Tuesday, November 11, 2025 claim interpretation epo G1 24 G1/24 patents PatKat Rose Hughes +
Trade mark piracy does not constitute bad faith – Really? By Marcel Pemsel on Monday, November 10, 2025 bad faith ferrari German Supreme Court Marcel Pemsel SIMCA Testarossa trade marks +